I
Immunome D
D
IMNM
8.75500
USD
-0.07
(-0.74%)
مغلق
حجم التداول
14,814
الربح لكل سهم
0
العائد الربحي
-
P/E
-3
حجم السوق
761,792,932
العنوان: Immunome
القطاع: Healthcare
الصناعة: Biotechnology
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.